Skip to main content
Premium Trial:

Request an Annual Quote

Sema4: William Oh

Sema4 has appointed William Oh to the position of chief medical science officer, where he will drive strategy, scientific collaborations, clinical development, and adoption of the firm's technology.

Oh comes to Sema4 from Mount Sinai Health System, where he was chief of hematology and medical oncology and the deputy director of the Tisch Cancer Institute at the Icahn School of Medicine. He will continue to see patients at Mount Sinai.

Oh holds an MD from the New York University School of Medicine.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.